These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 4790141)

  • 1. [Pharmacokinetics of tolbutamide and glycodiazine in liver and kidney diseases].
    Held H; Eisert R; von Oldershausen HF
    Verh Dtsch Ges Inn Med; 1973; 79():1220-3. PubMed ID: 4790141
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics of glymidine (glycodiazine) and tolbutamide in acute and chronic liver diseases.
    Held H; Eisert R; von Oldershausen HF
    Arzneimittelforschung; 1973 Dec; 23(12):1801-7. PubMed ID: 4801689
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the pharmacokinetics of sulfamethoxypyrazine in chronic liver and kidney diseases].
    Held H; von Berger L; von Oldershausen HF
    Arzneimittelforschung; 1969 Jan; 19(1):98-100. PubMed ID: 5819372
    [No Abstract]   [Full Text] [Related]  

  • 4. [Influence of liver diseases and kidney function disorders and phenylbutazone, phenprocoumarol and doxycycline on the excretion of glycodiazine].
    Held H; Kaminski B; von Oldershausen HF
    Diabetologia; 1970 Aug; 6(4):386-91. PubMed ID: 5452388
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of some salicylates and sulfonamides on binding by albumin of SPC-703 and tolbutamide.
    Wójcikowski C; Szlabowicz D
    Pol J Pharmacol Pharm; 1976; 28(2):129-35. PubMed ID: 945561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes of pharmacokinetics of oral antidiabetics from drug interference and renal insufficiency].
    Berger W; Spring P
    Dtsch Med Wochenschr; 1970 Dec; 95(50):2525-7. PubMed ID: 5488752
    [No Abstract]   [Full Text] [Related]  

  • 7. [Simulation of the biodynamics of glycodiazine with the analog computer].
    Riemann J; Röpke H; Gerhards E; Kolb KH; Gibian H
    Arzneimittelforschung; 1968 Nov; 18(11):1443-5. PubMed ID: 5756066
    [No Abstract]   [Full Text] [Related]  

  • 8. [On 2-benzolsulfonylamino-5(beta-methoxy-ethoxy)-pyrimidine (glycodiazine. V. In vitro and in vivo experiments on the action of phenylethylbarbituric acid (Luminal) on the metabolism and blood sugar reducing effect of glycodiazine].
    Gerhards E; Kolb KH; Schulze PE
    Naunyn Schmiedebergs Arch Pharmakol Exp Pathol; 1966; 255(2):200-20. PubMed ID: 4228177
    [No Abstract]   [Full Text] [Related]  

  • 9. [Spectrofluorometric method for determination of glycodiazine in plasma and of the both glycodiazine metabolites in urine].
    Held H; Kaminski B; von Oldershausen HF
    Arzneimittelforschung; 1970 Dec; 20(12):1927-9. PubMed ID: 5537100
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hypoglycemic effect of glycodiazine and tolbutamide on rats with normal metabolism, as well as the effect of glycodiazine on the glucose-6-phosphatase of the liver of rats in vitro].
    Hildmann W; Schümann R
    Arzneimittelforschung; 1966 Apr; 16(4):568-70. PubMed ID: 4294367
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pharmacokinetics of blood glucose lowering sulfonamides].
    Krüger-Thiemer E; Bünger P; Seydel JK
    Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():74-104. PubMed ID: 4906027
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical pharmacokinetics of sulphonylurea hypoglycaemic drugs.
    Balant L
    Clin Pharmacokinet; 1981; 6(3):215-41. PubMed ID: 7016385
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of insulin and glycodiazine on the level of plasma free fatty acids in bilharzial (schistosomal) hepatic fibrosis.
    Ghanem MH; Guirgis FK
    J Trop Med Hyg; 1972 Jun; 75(6):115-8. PubMed ID: 5044326
    [No Abstract]   [Full Text] [Related]  

  • 14. [2-Benzolsulfonamido-5(beta-methoxy-ethoxy)-pyrimidine (Glycodiazine). II. Metabolism of 2-benzolsulfonamido-5(beta-hydroxy-ethoxy)-pyrimidine, a blood sugar reducing metabolite of glycodiazine in man].
    Gerhards E; Kolb KH
    Arzneimittelforschung; 1965 Dec; 15(12):1375-9. PubMed ID: 5899812
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pharmacokinetics of antihypertensive drugs in kidney and liver diseases].
    Knauf H; Mutschler E
    MMW Munch Med Wochenschr; 1983 Nov; 125(45):1037-40. PubMed ID: 6139750
    [No Abstract]   [Full Text] [Related]  

  • 16. [A new hypoglycemic sulfonamide: AN1324].
    Vignalou J; Beck H
    Presse Med (1893); 1968 Oct; 76(38):1827-8. PubMed ID: 5737547
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hypoglycemic complications induced by hypoglycemic sulfonamides. Recall of pharmacological basis of their therapeutic use].
    Hazard J
    Nouv Presse Med; 1976 Apr; 5(14):903-5. PubMed ID: 1272759
    [No Abstract]   [Full Text] [Related]  

  • 18. [A comparative study of blood sugar, insulinemia and sulfamidemia after oral administration of 1 g of glymidine (glycodiazine)].
    Jaquet P; Soyfer JC; Aprile N; Cristau B; Codaccioni JL
    Diabete; 1971; 19(1):33-6. PubMed ID: 5571511
    [No Abstract]   [Full Text] [Related]  

  • 19. [Intravenous tolbutamide test during hepatic disorders of chronic alcoholism].
    Cruz A; David H; Thervet F; Rambert P; Benard H
    Diabete; 1969; 17(1):29-32. PubMed ID: 5791572
    [No Abstract]   [Full Text] [Related]  

  • 20. Stimulation of tolbutamide hydroxylation by acetone and acetonitrile in human liver microsomes and in a cytochrome P-450 2C9-reconstituted system.
    Palamanda J; Feng WW; Lin CC; Nomeir AA
    Drug Metab Dispos; 2000 Jan; 28(1):38-43. PubMed ID: 10611138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.